Cases 21 - 30 of 637
KENNEDY v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv13282
Plaintiff:
ROBERT KENNEDY
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant:
LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
WOJNICKI v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04496
Plaintiff:
JAMES WOJNICKI
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2023cv00877
Plaintiff:
Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SMITH v. AUROBINDO PHARMA USA, INC. et al
as 1:2023cv04166
Plaintiff:
ANTOINETTE MARIE SMITH
Defendant:
AUROBINDO PHARMA USA, INC., CAMBER PHARMACEUTICALS, INC., JOHNS DOE 1-11 and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WORTHEN et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04163
Plaintiff:
GARY L. WORTHEN and LOLA E. WORTHEN
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HILL et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04125
Plaintiff:
REGINA HILL and BARRY HILL
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03909
Plaintiff:
KENNETH W. WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
OWENS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03747
Plaintiff:
ANGELA OWENS
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
